エピレプシーのリスクは,臨床診察でどのように紹介され,議論されるか
Cordet Smart1, Hannah Cock2, Phil Tittensor3
1Director of Professional Doctorates and Clinical Associate Psychology, Exeter University, United Kingdom.
Patient education and counseling
|August 29, 2025
まとめ
急性予期せぬ死 (SUDEP) のようなのリスクについて話し合うことは困難です. 臨床医は患者の理解に合わせてリスクの議論をすべきですが,直感はしばしばのリスクを管理するためのより良い関与を好みます.
科学分野:
- 神経学
- 医療 コミュニケーション
- 定性的な研究
背景:
- 怪我,うつ,突然の予期せぬ死 (SUDEP) を含むの有害な影響は,患者によって制御される要因によって軽減することができます.
- 新しいガイドラインでは 診断時にリスクについて話し合うことを推奨していますが 臨床医は患者の不安を理由に 躊躇しています
研究 の 目的:
- エピレプシー専門医が 専門診療所の患者と リスクについての議論をどのように開始するか 分析する.
- 敏感な会話の際の コミュニケーション戦略を理解する
主な方法:
- イギリスのエピレプシー専門の診療所での最初の24回の電話予約の分析
- ケーススタディと臨床医,研究者,患者との共同分析セッションを含む.
主要な成果:
- 勃発性のリスクは敏感で複雑で 交渉と患者の混乱に対処することが必要です
- 臨床医は質問と"暗示的な修復"技術を用いて 相互主観性を構築します
- これらの議論において 知覚的要因 (誰が何を知っているか) は極めて重要です
結論:
- 臨床医はしばしば 患者の知識を利用して 行動の変化を議論し 深刻なリスクの直接的な言及を避けます
- このアプローチは,より直接的なコミュニケーションを好む患者との相互作用の困難を引き起こす可能性があります.
- 患者をエピレプシーリスク管理に 巻き込むには リスク情報の慎重な調整と直接性が重要です
さらに関連する動画
09:16Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
Published on: June 21, 2019
25.8K
10:46Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery
Published on: September 1, 2023
3.4K
関連する概念動画
01:24Epilepsy and Seizures: Overview
275
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
275
01:13Seizures: Classification
584
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
584
01:30Electroconvulsive Therapy
182
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
182
01:20Antiepileptic Drugs: Potassium Channel Activators
274
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
274
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
445
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
445
01:17Antiepileptic Drugs: Calcium Channel Blockers
608
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
608